These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 17125594)

  • 1. Immunohistochemical evaluation of phosphorylated SMAD2/SMAD3 and the co-activator P300 in human glomerulonephritis: correlation with renal injury.
    Kassimatis TI; Giannopoulou I; Koumoundourou D; Theodorakopoulou E; Varakis I; Nakopoulou L
    J Cell Mol Med; 2006; 10(4):908-21. PubMed ID: 17125594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcription factor Sp1 expression is upregulated in human glomerulonephritis: correlation with pSmad2/3 and p300 expression and renal injury.
    Kassimatis TI; Nomikos A; Giannopoulou I; Lymperopoulos A; Moutzouris DA; Varakis I; Nakopoulou L
    Ren Fail; 2010 Jan; 32(2):243-53. PubMed ID: 20199187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Smad pathway activation on podocyte cell cycle regulation: an immunohistochemical evaluation.
    Koutroutsos K; Kassimatis TI; Nomikos A; Giannopoulou I; Theohari I; Nakopoulou L
    Ren Fail; 2014 Sep; 36(8):1310-6. PubMed ID: 25026939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Smad3 is acetylated by p300/CBP to regulate its transactivation activity.
    Inoue Y; Itoh Y; Abe K; Okamoto T; Daitoku H; Fukamizu A; Onozaki K; Hayashi H
    Oncogene; 2007 Jan; 26(4):500-8. PubMed ID: 16862174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Smad2 Phosphorylation in Diabetic Kidney Tubule Epithelial Cells Is Associated with Modulation of Several Transforming Growth Factor-β Family Members.
    Høj Thomsen L; Fog-Tonnesen M; Nielsen Fink L; Norlin J; de Vinuesa AG; Krarup Hansen T; de Heer E; Ten Dijke P; Rosendahl A
    Nephron; 2017; 135(4):291-306. PubMed ID: 28064277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acetylation of Smad2 by the co-activator p300 regulates activin and transforming growth factor beta response.
    Tu AW; Luo K
    J Biol Chem; 2007 Jul; 282(29):21187-96. PubMed ID: 17478422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA fragmentation in chronic glomerulonephritis: an immunohistological analysis.
    Ott U; Aschoff A; Pocock J; Fünfstück R; Jirikowski G; Stein G; Wolf G
    Nephron Clin Pract; 2007; 105(1):c18-28. PubMed ID: 17114899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transforming growth factor-beta(1) and myofibroblasts: a potential pathway towards renal scarring in human glomerular disease.
    Goumenos DS; Tsamandas AC; Oldroyd S; Sotsiou F; Tsakas S; Petropoulou C; Bonikos D; El Nahas AM; Vlachojannis JG
    Nephron; 2001 Mar; 87(3):240-8. PubMed ID: 11287759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The transcriptional co-activator P/CAF potentiates TGF-beta/Smad signaling.
    Itoh S; Ericsson J; Nishikawa J; Heldin CH; ten Dijke P
    Nucleic Acids Res; 2000 Nov; 28(21):4291-8. PubMed ID: 11058129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IN-1130, a novel transforming growth factor-beta type I receptor kinase (ALK5) inhibitor, suppresses renal fibrosis in obstructive nephropathy.
    Moon JA; Kim HT; Cho IS; Sheen YY; Kim DK
    Kidney Int; 2006 Oct; 70(7):1234-43. PubMed ID: 16929250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Constitutively phosphorylated Smad3 interacts with Sp1 and p300 in scleroderma fibroblasts.
    Ihn H; Yamane K; Asano Y; Jinnin M; Tamaki K
    Rheumatology (Oxford); 2006 Feb; 45(2):157-65. PubMed ID: 16319104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Localization of TGF-beta signaling intermediates Smad2, 3, 4, and 7 in developing and mature human and mouse kidney.
    Banas MC; Parks WT; Hudkins KL; Banas B; Holdren M; Iyoda M; Wietecha TA; Kowalewska J; Liu G; Alpers CE
    J Histochem Cytochem; 2007 Mar; 55(3):275-85. PubMed ID: 17142805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TGF-β1-induced epithelial-mesenchymal transition and acetylation of Smad2 and Smad3 are negatively regulated by EGCG in human A549 lung cancer cells.
    Ko H; So Y; Jeon H; Jeong MH; Choi HK; Ryu SH; Lee SW; Yoon HG; Choi KC
    Cancer Lett; 2013 Jul; 335(1):205-13. PubMed ID: 23419524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of signal transducer and activator of transcription 3 correlates with cell proliferation and renal injury in human glomerulonephritis.
    Arakawa T; Masaki T; Hirai T; Doi S; Kuratsune M; Arihiro K; Kohno N; Yorioka N
    Nephrol Dial Transplant; 2008 Nov; 23(11):3418-26. PubMed ID: 18556750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of bcl-2 oncoprotein in various types of glomerulonephritis and renal allografts.
    Nakopoulou L; Stefananki K; Papadakis J; Boletis J; Zeis PM; Kostakis A; Vosnides G
    Nephrol Dial Transplant; 1996 Jun; 11(6):997-1002. PubMed ID: 8671959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pentoxifylline Attenuates Proteinuria in Anti-Thy1 Glomerulonephritis via Downregulation of Nuclear Factor-κB and Smad2/3 Signaling.
    Chen YM; Chiang WC; Yang Y; Lai CF; Wu KD; Lin SL
    Mol Med; 2015 Apr; 21(1):276-84. PubMed ID: 25879629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transforming growth factor-β promotes aggressiveness and invasion of clear cell renal cell carcinoma.
    Sitaram RT; Mallikarjuna P; Landström M; Ljungberg B
    Oncotarget; 2016 Jun; 7(24):35917-35931. PubMed ID: 27166254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transforming growth factor-beta- and Activin-Smad signaling pathways are activated at distinct maturation stages of the thymopoeisis.
    Rosendahl A; Speletas M; Leandersson K; Ivars F; Sideras P
    Int Immunol; 2003 Dec; 15(12):1401-14. PubMed ID: 14645149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regionally different immunoreactivity for Smurf2 and pSmad2/3 in TDP-43-positive inclusions of amyotrophic lateral sclerosis.
    Nakamura M; Kaneko S; Wate R; Asayama S; Nakamura Y; Fujita K; Ito H; Kusaka H
    Neuropathol Appl Neurobiol; 2013 Feb; 39(2):144-56. PubMed ID: 22435645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphorylated Smad2/3 immunoreactivity in sporadic and familial amyotrophic lateral sclerosis and its mouse model.
    Nakamura M; Ito H; Wate R; Nakano S; Hirano A; Kusaka H
    Acta Neuropathol; 2008 Mar; 115(3):327-34. PubMed ID: 18210139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.